Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

0.83
Delayed Data
As of Jun 23
 +0.01 / +1.22%
Today’s Change
0.26
Today|||52-Week Range
1.51
+86.52%
Year-to-Date
No recent news for Protalix Biotherapeutics Inc.

Today’s Trading

Previous close0.82
Today’s open0.81
Day’s range0.81 - 0.83
Volume606,025
Average volume (3 months)2,400,069
Market cap$105.0M
Dividend yield--
Data as of 4:01pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-251.54%
Earnings growth (this year)-10.34%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+110.79%
P/E ratioNM
Price/Sales4.90
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PFNXPfenex Inc-0.39-8.07%
CYTRCytRx Corp-0.02-3.08%
CBMGCellular Biomedicine...-0.40-4.82%
--Wang On Group Ltd-0.00-14.29%
Data as of 4:11pm ET, 06/23/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$9.2M
Annual profit (last year)-$29.4M
Net profit margin-317.16%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
Moshe Manor
Chief Operating Officer
Tzvi Palash
Corporate headquarters
Carmiel, Hazafon

Forecasts